Goldman Sachs has raised its price target for Coinbase to $196 from $173 while maintaining its Buy rating, citing potential upside from an improving cryptocurrency market and continued expansion into newer business areas, according to a CNBC report shared by @WuBlockchain on X.

Canaccord separately increased its price target for Strategy to $175 from $130, also keeping its Buy rating in place. The firm said the setup for MSTR has materially improved in recent weeks.

The moves formed part of a broader round of analyst changes across the technology and financial sectors. Raymond James upgraded AMD to Strong Buy, Bank of America remained positive on Nvidia, Micron and Marvell, and Moderna, Dynatrace and Shift4 Payments each received rating upgrades.

Goldman Raises Coinbase Target to $196

Goldman Sachs lifted its Coinbase target by $23 to $196 while reaffirming its Buy recommendation. The revision reflects what the bank sees as additional upside from a sustained improvement in the cryptocurrency market, together with Coinbase's ongoing expansion into newer business lines such as derivatives and prediction markets.

Coinbase has developed beyond its traditional role as a cryptocurrency trading platform, with additional products now contributing to the company's broader business strategy. Goldman's assessment indicates that the potential growth of these newer businesses is an important factor in its updated valuation. The revised target therefore incorporates both the market conditions affecting cryptocurrency activity and Coinbase's efforts to diversify its sources of revenue.

The unchanged Buy rating signals that Goldman continues to view the stock favorably. For readers tracking the company, the update is notable because it ties a valuation change to both market conditions and Coinbase's push to broaden its product mix, not just to trading activity alone.

Canaccord Lifts Strategy Target to $175

Canaccord raised its price target for Strategy to $175 from $130 — a $45 increase — while retaining its Buy rating. According to the information shared on X, Canaccord said the setup for MSTR has materially improved in recent weeks.

Strategy is closely associated with the cryptocurrency market because of its substantial Bitcoin holdings, and changes in the value of Bitcoin remain an important consideration when investors evaluate the company and its stock.

The increase from $130 to $175 represents a significant revision to Canaccord's previous target. However, the firm did not provide additional details in the information supplied about the specific factors behind the improvement in its assessment. The continued Buy rating means Canaccord has maintained its positive view of the stock despite the change in its price objective. In practice, that keeps investor attention on how market sentiment and Bitcoin exposure can shape Wall Street views of the company.

Analysts Remain Positive on Major Technology Stocks

The broader analyst activity extended beyond cryptocurrency-related companies.

Raymond James upgraded AMD to Strong Buy, a stronger recommendation for the semiconductor company. AMD is one of several major chipmakers benefiting from continued investor attention toward the technology sector.

Bank of America, meanwhile, remained positive on Nvidia, Micron and Marvell. The three companies operate across different segments of the semiconductor and technology supply chain, with their businesses connected to demand for computing and advanced electronic infrastructure. By maintaining its stance, the bank indicated that it continues to see favorable prospects for all three.

Taken together, the analyst actions demonstrate that investor attention remains concentrated on companies exposed to major technology trends, including semiconductors and digital assets. That mix of upgrades and maintained positive ratings also shows how analysts are reassessing multiple corners of the market at the same time, rather than focusing on a single theme.

Moderna, Dynatrace and Shift4 Also Upgraded

Several other companies also received rating upgrades. Moderna, Dynatrace and Shift4 Payments were among the companies whose ratings were raised, according to the information shared by @WuBlockchain.

The upgrades add to a broader set of analyst revisions spanning technology, healthcare and payments-related businesses. While the reasons for each individual upgrade were not detailed in the information provided, the changes indicate that analysts are reassessing companies across several industries.

Crypto Market Conditions Remain a Key Factor

The Coinbase and Strategy revisions are particularly notable because both companies have significant exposure to developments in the cryptocurrency market.

Goldman's decision to raise Coinbase's target was explicitly linked to expectations of sustained improvement in crypto-market conditions and growth in derivatives and prediction markets. Canaccord's higher Strategy target similarly reflects an improved assessment of the company's recent setup.

The two revisions come as analysts continue to evaluate how cryptocurrency market conditions can affect publicly traded companies with direct or indirect exposure to digital assets. For Coinbase, the expansion of derivatives and prediction markets provides additional areas of business activity beyond its core cryptocurrency operations. For Strategy, its connection to Bitcoin remains an important consideration in how the company is evaluated by investors.

The latest analyst actions do not guarantee future stock performance, but they provide an indication of how major financial institutions are currently assessing several prominent companies. Goldman's $196 Coinbase target and Canaccord's $175 Strategy target represent upward revisions from their previous levels, while the additional upgrades across technology, healthcare and payments companies reflect a broader round of changes in Wall Street recommendations.